Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor

Journal of Molecular Neuroscience

Volumn 11, Issue 2, 1998, Pages 127-134

  Olde, Björn ^a   Sabirsh, Alan ^a   Owman, Christer ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chimeric receptors; Human VIP receptor; Ligand activation; Secretin receptor

Indexed keywords

CYCLIC AMP; EPITOPE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; LIGAND; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROTRANSMITTER; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CHIMERA; EPITOPE MAPPING; GENE CONSTRUCT; HYBRIDIZATION; LIGAND BINDING; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

ANIMALIA; MURINAE;

EID: 0032469805     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:11:2:127     Document Type: Article

References (21)

1. Arimura A. and Said S. S., eds. (1996) VIP, PACAP, and related peptides. Ann. NY Acad. Sci. 805,1-792.
2. Beaubien B., Tippins J. R., and Morris H. R. (1984) Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. Biochem. Biophys. Res. Com. 125, 105-108.
3. Barik S. and Galinski M. S. (1991) "Megaprimer" method of PCR: increased template concentration improves yield. BioTechniques 10, 489,490.
4. Bolin D. R., Michalewsky J., Wasserman M. A., and O'Donnel M. (1995) Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma. Biopolymers 37, 57-66.
5. Buggy J. J., Livingston J. N., Rabin D., and Warren H. Y. (1995) Glucagon, glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding. J. Biol. Chem. 270, 7474-7478.
6. Gether U., Johansen T. E., and Schwartz T. W. (1993) Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. J. biol. Chem. 268, 7893-7898.
7. Gourlet P., Vilardaga J.-P., De Neef P., Waelenbroeck M., Vandemeers A., and Robberecht P. (1996) The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides 17, 825-829.
8. Hjorth S. A., Adelhorst K., Pedersen Brogaard B., Kirk O., and Schwartz T. (1994) Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes. J. Biol. Chem. 269, 30,121-30,124.
9. Holtmann M. H., Hadac E. M., and Miller L. J. (1995) Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J. Biol. Chem. 270, 14,394-14,398.
10. Horton R. M., Cai Z., Ho S. N., and Pease L. R. (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8, 528-535.
11. i coupled receptors. Mol. Cell. Neurosci. 2, 331-337.
12. Lardelli M. and Lendahl U. (1994) Generating bacteriophage lambda sublibraries enriched for rare clones. BioTechniques 16, 420-422.
13. Lefebre B., Formstecher P., and Lefebre P. (1995) Improvement of the gene splicing overlap (SOE) method. BioTechniques 19, 186-188.
14. Ollerenshaw S., Jarvis D., Woolcock A., Sullivan C., and Scheibner T. (1989) Absence of immunoreactive intestinal polypeptide in tissue from the lungs of patients with asthma. New Engl. J. Med. 320, 1244-1248.
15. Patel D. P., Kong Y., and Sreedharan S. P. (1995) Molecular cloning and expression of a human secretin receptor. Mol. Pharm. 47, 467-473.
16. Pont-Kingdon G. (1994) Construction of chimeric molecules by a two-step recombinant PCR method. BioTechniques 16, 1010,1011.
17. Sarkar G. and Sommer S. S. (1990) The "megaprimer" method of site-directed mutagenesis. BioTechniques 8, 404-407.
18. Segre G. V. and Goldring S. R. (1993) Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone and glucagon belong to a newly discovered G-protein-linked receptor family. Trends Endocrinol. Metab. 4, 309-314.
19. Tarns J., Knudsen S. M., and Fahrenkrug J. (1998) Proposed arrangement of the seven transmembrane helices in the secretin receptor family. Rec. Channels 5, 79-90.
20. Trotz M. E. and Said S. L. (1993) Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro. Regul. Pept. 48, 301-307.
21. Vilardaga J-P., De Neef P., Di Paolo E., Bollen A., Waelbroeck M., and Robberecht P. (1995) Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem. Biophys. Res. Commun. 211, 885-891.